Laboratory Request Form Completion and Specimen Labelling Reference Number:

Similar documents
Right Patient Right Blood Monitoring Compliance Reference Number:

REQUEST FORM AND SPECIMEN LABELLING POLICY CG45

Specimen and Request Form Labelling Policy

Use of Intravenous devices for administration of fluid therapy in Neonates

Private Practice by Medical Staff - Code of Conduct

Assessment criteria for obtaining a venous blood sample

Pathology Service User Handbook GENERAL SERVICE INFORMATION FOR LABORATORY SERVICE USERS

PROCEDURE FOR TAKING AND LABELLING A TRANSFUSION SAMPLE AND COMPLETING THE REQUEST FORM

A Guide To Safe Blood Transfusion Practice

Laboratory Services. Specimen Collection & Rejection Procedure

Sample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee

Assistance and Administration of Medication for Domiciliary Care Staff

Safe Blood Transfusion

Intravenous Fluid Administration and Addition of Medicines to Intravenous Fluids (Drug Additives) (In-Patient Facilities) Interim Nursing Procedure

Observation and Therapeutic Engagement of Mental Health Inpatients in Holywell Hospital and Ross Thomson Unit Reference Number:

HAEMOVIGILANCE. Ms. Emma O Riordan Haemovigilance, CNM2 (Acting) Ms. Bríd Doyle, MSc. FAMLS. Haemovigilance Co-ordinator, (Acting)

Preanalytical Errors in Laboratory - Their Consequences and Measures to Reduce Them

Policy for Patient Identification. Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead:

Blood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.

Blood Administration for Community Patients Policy

Standard Operating Procedure for Patients Referred for Blood Transfusion to Louth Clinical Decision Unit by General Practitioners.

SPECIMEN REQUIREMENTS

Northern Ireland Single Assessment Tool (NISAT)

Competency Framework for the Administration of all Blood Products

Trust Policy for Blood Transfusion

Patient Identification Policy

CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS

Registration of Health and Social Care Professions

Policy on Gaining Consent

Objectives. With the completion of this module the learner will:

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016

Lessons for Transfusion Laboratory Staff. from the 2007 SHOT Report SHOT SERIOUS HAZARDS OF TRANSFUSION

For an informal discussion, please contact Geoff Day, Laboratory Manager on or

Booking of Non-Emergency Ambulances

COPY. That all specimens received by the lab are properly labeled by person collecting the specimen

Patient Identification Policy

Document Number: QAQC.81.Proc Manual: Quality Assurance Quality Control. Version: 002 Publish Date: March 2013

PATHOLOGY SPECIMEN ACCEPTANCE AND REJECTION POLICY

Job Description. TDL Laboratory Staff, Clients and Customers, Group Blood Transfusion Manager

General Practitioner Pathology - Laboratory Service Provision Policy Policy No: SJH: LabMed (P):003

Internal Quality Assurance Framework Microbiology

AN AUDIT OF P LATELET USE AT CMFT A SURVEY OF EMP OWERMENT IN THE LABORATORY

POL:02:UP:001:07:NIBT PAGE 1 of 6 ISSUE DATE: 12 DECEMBER 2014 EFFECTIVE DATE: 9 JANUARY 2015

Policy Checklist. Working Group: Administration of Infusion of Intravenous Fluids & Medicines in Neonates (Chairperson: Dr Hogan) YES

REPOSITIONING OUR CLINICAL LABORATORIES FOR EFFECTIVE AND EFFICIENT HEALTHCARE DELIVERY. By Prof. Ibironke Akinsete Chairman PathCare Nigeria

BIOMEDICAL SCIENTIST MEDIA INFORMATION 2017

Internal Quality Assurance Framework Clinical Forensic Medicine

REPORT OF BLOOD SAFETY REVIEW

TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN ENGLAND NOVEMBER 2016

Medicines Management Strategy

POL:08:LP:003:03:NIBT PAGE : 1 of 5. Document Title: NIBTS POLICY FOR RETURN AND RE-ISSUE OF BLOOD AND BLOOD COMPONENTS

STANDARDS Point-of-Care Testing

Guidance on Quality Management in Laboratories

Anaphylactic Reaction Emergency Treatment Reference Number:

Linen Services and Patients Personal Clothing

Supervision of Biomedical Support Staff (Assistant and Associate Practitioners)

BLOOD TRANSFUSION POLICY

Pre-Analytical Laboratory Procedures for Medical Office Staff CLP 011a-001 Revised March, 2007

Job Description. Senior Biomedical Scientists & Head and Deputy Head of Department. Head of Department (Biochemistry) & Blood Sciences Manager

Blood Products Policy

Pathology User Survey

POL:00:QP:001:03:NIBT PAGE 1 of 8. Document Details Document Number: POL:00:QP:001:03:NIBT No. of Appendices: 1 Supersedes Number: 00:02:QP:001:NIBT

Barbara De la Salle UK NEQAS

The clinical scientist in pathology. March 2005

Complaint from the Institute of Biomedical Science (IBMS)

Pretransfusion Testing Specimen Collection TRAINING GUIDE TM T-08

Blood / Blood Products Transfusion A Liquid Transplant

Speech and Language Therapy

Blood Transfusion Competency Assessment Assessor Pack

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Medical Laboratory Scientist/ Technologist Pathology Service. Medical Laboratory Scientist/Technologist. Pathology Service

Irradiated blood products - Pathway for requesting To provide healthcare professionals with clear guidance on the use of irradiated blood products.

Disclosures. Relevant Financial Relationship(s): Nothing to Disclose. Off Label Usage: Nothing to Disclose 6/1/2017. Quality Indicators

Competency Assessment for Non Medical Prescribing of Blood and Blood Components

Palliative Management of Major Haemorrhage in an Adult Patient with Advanced Cancer Reference Number:

SARASOTA MEMORIAL HOSPITAL

Changes in practice and organisation surrounding blood transfusion in NHS trusts in England

Martin Health System Stuart, Florida Laboratory Services. Laboratory Services and Policies

Dominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary

Nursing APEL for Mentoring Programme

Supervision Guidance for Physiotherapy Staff

Specimen Transport Procedure

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING

DOCUMENT CONTROL Patient Identification Policy 6 CL001

HYWEL DDA LOCAL HEALTH BOARD. Transfusion Policy. Completed Action: Addresses all aspects of transfusion with blood and blood components

CLINICAL CHEMISTRY. Phone: The department is staffed 24 hours a day.

Critical Care in Obstetrics Guideline

POCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014)

POLICY FOR TAKING BLOOD CULTURES

Better Blood Transfusion & anti-d Immunoglobulin

Hazard Analysis & Critical Control Points

Do Not Attempt Resuscitation Policy

All Wales Multidisciplinary Medicines Reconciliation Policy

Institute for Quality Management in Healthcare (IQMH) Toronto, Ontario, Canada. Janice Nolan, Executive Director, Programs

Internal Quality Assurance Framework Anatomical Pathology

Standards for Laboratory Accreditation

JOINT CODE OF PRACTICE FOR RESEARCH

Clinical Governance & Risk Management Awareness. Incl. investigation of accidents, complaints and claims. Unit 2

FREQUENTLY ASKED QUESTIONS (FAQS) FOR THE INDIVIDUAL HEALTH IDENTIFIER (IHI) JANUARY 2016

LABORATORY SPECIMEN ID REPORT FEBRUARY 2018

Transcription:

This is an official Northern Trust policy and should not be edited in any way Laboratory Request Form Completion and Specimen Labelling Reference Number: NHSCT/12/582 Target audience: This policy is directed to all phlebotomists, healthcare assistants, nurses and doctors who complete laboratory request forms or label sample containers. Sources of advice in relation to this document: Maureen Entwistle, Pathology Quality Manager David Wallace, Acting Assistant Director Clinical & Diagnostic Services Replaces (if appropriate): Northern Trust Laboratory Request Form Completion and Specimen Labelling (HSCT/10/333) Type of Document: Trust Wide Approved by: Policy, Standards and Guidelines Committee Date Approved: 28 June 2012 Date Issued by Policy Unit: 30 August 2012 NHSCT Mission Statement To provide for all the quality of services we would expect for our families and ourselves

Laboratory Request Form Completion and Specimen Labelling 24 April 2012 Version 1_1

Laboratory Request Form Completion & Specimen Labelling Introduction In accordance with best practice guidelines and Standard E5.2 (CPA UK) the Clinical Pathology Laboratory in the Northern Trust has a strict policy in regard to the acceptance or rejection of specimens. It is intended to ensure that the right investigation is performed on the right specimen. The Minimum Data Set is a nationally agreed set of standards for the appropriate labelling of samples and completion of request forms. It is the responsibility of the requestor to ensure that samples are labelled correctly and request forms are completed at least to these minimum standards. Unequivocal identification is essential to prevent attribution of results to the wrong patient and to avoid multiple computer entries for the same patient. Request forms and/or specimens with inadequate, inaccurate or illegible information inevitably disrupt laboratory processing causing unnecessary delay. Where there is a possibility of risk of potentially serious error, there is no alternative but to reject the specimen. In line with DHSSPSNI Safer Practice Circular 05/09 the Health and Care number (HCN) should be the unique identification number used for patients; the local hospital number may be used alongside the HCN but NOT instead of it. Recent audits of the completion of laboratory request forms revealed that 52% had no Consultant detail; 5% no time of sampling; 2% no ward and 25% of handwritten forms had no patient gender. Purpose This policy outlines the essential patient identifiers and information required on both laboratory request forms and specimen containers. Target Audience This policy is directed to all phlebotomists, healthcare assistants, nurses and doctors who complete laboratory request forms or label sample containers. 1

Responsibilities The responsibility for compliance with the standard requirements for requesting a laboratory service / test lies with the patient s clinician even when the requesting process is delegated to other staff acting on their behalf. It is therefore the responsibility of the requestor to ensure that specimen containers are correctly labelled and that request forms are completed to the required standard. It is recognised that there may be circumstances in which exceptional procedures need to be applied e.g. where the identity of the patient or other standard information is unknown, where the patient is not easily accessible for a repeat test or where the repeat sample would not have the same clinical significance. This policy sets out the procedures to be followed in such cases. Policy Statement Specimens will not be accepted for analysis where: 1. The essential criterion in the Minimum Data Set is not met on either the form or the specimen container. 2. The specimen has been collected inappropriately e.g. unsuitable anticoagulant or preservative. 3. The integrity of the specimen is in question e.g. leaked in transit, undue delay in transport. 4. The specimen is unlabelled. 5. The specimen is incorrectly labelled to such a degree as to compromise reliable identification of the patient The subsequent action will be determined by the Biomedical Scientists but may include:- Requesting a fresh specimen and form Processing the specimen but withholding results Storing the specimen in a manner appropriate for later analysis At the discretion of Senior Biomedical Scientists the requestor may be contacted for ward & consultant details required to complete the minimum data set; any modification to the request form is recorded. The requestor will be required to complete any missing data in the laboratory only in exceptional circumstances will samples be returned to sender. All blood bank samples / request forms that do not conform to the minimum data set will be rejected. Point of Care Samples All Point of Care record sheets and specimen containers (where appropriate) must also contain the ESSENTIAL information. 2

Minimum Data Set for all pathology requests except Blood Transfusion On occasion some of the desirable data may be essential; it is preferable to supply all of the information detailed below to ensure that the patient is not inconvenienced or put at unnecessary risk due to delay in provision of results. For example serum Potassium rises significantly within 2 hours of sampling whilst other analytes are stable for a longer period; therefore the time of sampling may be essential. Essential Specimen Desirable Health and Care Number (HCN) Date & Time Destination for report Request Form HCN Gender (except Cellular & Molecular Pathology) Patient s location and destination for report Patient s Consultant, GP or name of requesting practitioner Investigations required Relevant Clinical information* Date & Time of sampling** Patient s address Contact number of requestor in the event of further communication being required Hazard Group 3 (Cat 3) Hazard Sticker if applicable *For Cellular and Molecular Pathology specimens relevant patient clinical history, source and type of specimen and the identity of the requesting practitioner are essential criteria on the request form. The DoB and / or HCN are acceptable on the sample in addition to the patient s full name. *For Microbiology specimens relevant clinical history, source of specimen and current antibiotics are essential criteria on the request form. **Date and time of sample is highly desirable for Biochemistry requests and some analytes, e.g. Potassium, will not be reported if date and time of sample is not provided Where addressograph labels are used for sample containers care must be taken to ensure that the sample in the tube is not totally obscured by the label; Biomedical Scientists in the laboratory often need to see the blood level and consistency in the container. Where addressograph labels are used for request forms the patient s location and Consultant must be added. Results cannot be reported if the source and location of the request is in doubt. Note that the GP cypher number alone is not sufficient. In the case of an unconscious patient or for reasons of confidentiality the coded PID s are acceptable. 3

Blood transfusion The requirements of the NPSA SPN 14 Right patient, right blood competency 1 Obtaining a venous sample for pre-transfusion testing must be adhered to. The details on the request form and specimen container must tally with the details on the patient s wristband. Specimen Request Form Essential Hospital number / unique identifier Date & Time Signature of person taking specimen details MUST be handwritten Hospital number / unique identifier Gender Patient s location and destination for report Patient s Consultant, GP or name of requesting practitioner Printed name, Signature, staff group & professional / Staff number of person taking sample Investigations required Date & Time of sampling Addressograph labels are acceptable on request forms ensure that all essential details are added Desirable Destination for report Transfusion history* Patient s postcode Hazard Group 3 (Cat 3) Hazard Sticker if applicable Additional information required if blood component / products are ordered Type & number of product required Special requirements if any Date / time / location of transfusion Reason for transfusion Recent Haemoglobin result with date Name, professional ID number / staff number and the signature of the person requesting the product *blood group / antibody history if known; previous / recent transfusions including date; previous transfusion reactions; obstetric history including recent anti-d administration (if applicable) 4

Equality, Human Rights and DDA This policy is purely clinical / technical in nature and will have no bearing in terms of its likely impact on equality of opportunity or good relations for people within the equality and good relations categories. Alternative Formats This document can be made available on request on disc, larger font, Braille, audio-cassette and in other minority languages to meet the needs of those who are not fluent in English. Sources of advice in relation to this document The Policy Author, responsible Assistant Director or Director as detailed on the policy title page should be contacted with regard to any queries on the content of this policy. References Patient Specimen and Request form Identification Criteria. The Institute of Biomedical Science (IBMS) BCSH Guidelines for compatibility procedures in blood transfusion laboratories Transfusion Medicine, 2004, 14, 59-73 NPSA Safer Practice Notice (14) Right Patient, Right Blood DHSSPSNI Safer Practice Circular 05/09 use of the Health and Care Number http://www.dhsspsni.gov.uk/sqs_learning_communication_05_09_- _use_of_health_and_care_number_.pdf 5

Biochemistry, Haematology, Microbiology, Histopathology & Blood Transfusion Requests Cytopathology requests Essential Desirable Essential Desirable Specimen Request Form HCN Gender Patient s location and destination for report Patient s Consultant, GP or name of requesting practitioner Investigations required Health and Care Number (HCN) Date & Time Destination for report Relevant Clinical information* Date & Time of sampling** Patient s address Contact number of requestor in the event of further communication being required *For Cellular and Molecular Pathology specimens relevant patient clinical history, source and type of specimen and the identity of the requesting practitioner are essential criteria on the request form. The DoB and / or HCN are acceptable on the sample in addition to the patient s full name. *For Microbiology specimens relevant clinical history, source of specimen and current antibiotics are essential criteria on the request form. **Date and time of sample is highly desirable for Biochemistry requests and some analytes, e.g. Potassium, will not be reported if date and time of sample is not provided NB addressograph labels DO NOT contain the patient s location or Consultant Specimen Request Form Additional information required if blood component / products are ordered Hospital number / unique identifier Date & Time Signature of person taking specimen details MUST be handwritten Hospital number / unique identifier Gender Patient s location and destination for report Patient s Consultant, GP or name of requesting practitioner Printed name, Signature, staff group & professional / Staff number of person taking sample Investigations required Date & Time of sampling Addressograph labels are acceptable on request forms ensure that all essential details are added Type & number of product required Special requirements if any Date / time / location of transfusion Reason for transfusion Recent Haemoglobin result with date Name, professional ID number / staff number and the signature of the person requesting the product Destination for report Transfusion history* Patient s postcode *blood group/antibody history if known; previous/recent transfusions including date; previous transfusion reactions; obstetric history including recent anti-d administration (if applicable) 6

7